Brain and Nervous System

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
ICT-107-301 (STING) A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ ChemoradiotherapyHirte, Dr HalOpenNCT02546102
IND.222A PHASE I/II STUDY OF THE mTORC1/mTORC2 KINASE INHIBITOR AZD2014 IN PATIENTS WITH PREVIOUSLY TREATED GLIOBLASTOMA MULTIFORMEHirte, Dr HalOpenNCT02619864
RTOG 3508/AbbVie M13-813 (Intellance 1)A Randomized, Placebo Controlled Phase 2b/3 Study of ABT-414 with Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects with Newly Diagnosed Glioblastoma (GBM) with Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance 1)Torres-Trejo, Dr AlejandroOpenNCT02573324
SABR-COMETStereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): A Randomized Phase II TrialSwaminath, Dr AnandOpenNCT01446744
SC.24A PHASE II RANDOMIZED FEASIBILITY STUDY COMPARING STEREOTACTIC BODY RADIOTHERAPY (SBRT) VERSUS CONVENTIONAL PALLIATIVE RADIOTHERAPY (CRT) FOR PATIENTS WITH SPINAL METASTASESGreenspoon, Dr JeffreyOpenNCT02512965
Download PDF